SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research note released on Sunday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reiterated a buy rating and issued a $35.00 price objective on shares of SenesTech in a research note on Tuesday, May 14th.

SenesTech Stock Performance

SenesTech stock opened at $4.81 on Friday. SenesTech has a 52 week low of $4.00 and a 52 week high of $112.87. The company’s 50 day moving average price is $6.06 and its two-hundred day moving average price is $7.53. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.91 and a quick ratio of 5.69.

SenesTech (NASDAQ:SNES) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($3.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.40) by ($0.20). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The company had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.43 million. During the same period last year, the firm posted ($158.50) earnings per share. On average, research analysts predict that SenesTech will post -11 EPS for the current year.

Hedge Funds Weigh In On SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new position in SenesTech, Inc. (NASDAQ:SNES) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech as of its most recent SEC filing. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.